Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  HYPERTENSION

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.35.1.25PMID 10642270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor.

  1998cited by this paper
• Nitric oxide induces and inhibits apoptosis through different pathways

  1998cited by this paper
• Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats.

  1998cited by this paper
• Kallikrein Gene Delivery Attenuates Hypertension and Cardiac Hypertrophy and Enhances Renal Function in Goldblatt Hypertensive Rats

  1998cited by this paper
• Human Kallikrein Gene Delivery Attenuates Hypertension, Cardiac Hypertrophy, and Renal Injury in Dahl Salt-Sensitive Rats

  1998cited by this paper
• Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms*

  1997cited by this paper
• Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.

  1996cited by this paper
• Apoptosis in ischemic and reperfused rat myocardium.

  1996cited by this paper
• Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.

  1996cited by this paper
• Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.

  1996cited by this paper
• Role of Kinins in the Pathophysiology of Myocardial Ischemia: In Vitro and In Vivo Studies

  1996cited by this paper
• Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.

  1995cited by this paper
• Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats.

  1995cited by this paper
• Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure

  1995cited by this paper
• Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

  1995cited by this paper
• Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

  1995cited by this paper
• A local kallikrein-kinin system is present in rat hearts.

  1994cited by this paper
• Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor.

  1992cited by this paper
• Bradykinin-mediated metabolic effects in isolated perfused rat hearts.

  1992cited by this paper
• Bioregulation of kinins: kallikreins, kininogens, and kininases.

  1992cited by this paper
• In Vivo Effect of Bradykinin During Ischemia and Reperfusion: Improved Electrical Stability Two Weeks After Myocardial Infarction in the Pig

  1991cited by this paper
• Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia‐induced arrhythmias in anaesthetized dogs

  1991cited by this paper
• Identification, purification, and localization of tissue kallikrein in rat heart.

  1990cited by this paper
• Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells.

  1990cited by this paper
• Examination of relative rates of cAMP synthesis and degradation in crude membranes of adipocytes treated with hormones.

  1990cited by this paper
• Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist.

  1990cited by this paper
• Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.

  1989cited by this paper
• The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation.

  1989cited by this paper
• The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion.

  1988cited by this paper
• Basic methods in molecular biology

  1986cited by this paper
• Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.

  1986cited by this paper
• Myocardial reperfusion: a double-edged sword?

  1985cited by this paper
• Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction.

  1985cited by this paper
• Limitation of Experimental Infarct Size by an Angiotensin‐converting Enzyme Inhibitor

  1982cited by this paper
• Prostacyclin release and the modulation of some vasoactive hormones.

  1980cited by this paper
• Radioimmunoassay of cyclic AMP and cyclic GMP.

  1979cited by this paper
• A sensitive radioimmunoassay method for urinary kinins in man.

  1978cited by this paper
• Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

  1975cited by this paper
• A comparison of the effects of locally and systemically administered kinins on coronary blood flow and myocardial metabolism.

  1966cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The Effect of Bradykinin B2 Receptor on Multiterritory Perforator Flap Survival in Rats: An Experimental Study.

  2025cites this paper
• Bradykinin-(1-9) mitigates autophagy through upregulating PI3K/Akt in rats with myocardial infarction.

  2023cites this paper
• Myocardial angiogenesis induced by exercise training involves a regulatory mechanism mediated by kinin receptors

  2021cites this paper
• The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction

  2020cites this paper
• Autocrine Bradykinin Release Promotes Ischemic Preconditioning-Induced Cytoprotection in Bovine Aortic Endothelial Cells

  2020cites this paper
• Pharmacological Inhibition of Serine Proteases to Reduce Cardiac Inflammation and Fibrosis in Atrial Fibrillation

  2019cites this paper
• Tissue kallikrein-related peptidase8 protects rat heart against acute ischemia reperfusion injury.

  2019cites this paper
• Effects of bradykinin on the survival of multiterritory perforator flaps in rats

  2019cites this paper
• The Long-Term Outcome Comparison of Different Time-Delayed Kallikrein Treatments in a Mouse Cerebral Ischemic Model

  2018cites this paper
• Daño por isquemia-reperfusión miocárdico en cirugía cardiaca con circulación extracorpórea. Aspectos bioquímicos

  2017cites this paper
• Effect of C1‐INH on ischemia/reperfusion injury in a porcine limb ex vivo perfusion model

  2017cites this paper
• Antihypertensive Role of Kidney: Focus on Tissue Kallikreins

  2017cites this paper
• Neuroprotection of bradykinin/bradykinin B2 receptor system in cerebral ischemia.

  2017cites this paper
• Therapeutic modulation of tissue kallikrein expression

  2016cites this paper
• Tongxinluo modulates cytokine secretion by cardiac microvascular endothelial cells in ischemia/reperfusion injury.

  2016cites this paper
• Regulator of G-protein signaling 5 protects cardiomyocytes against apoptosis during in vitro cardiac ischemia-reperfusion in mice by inhibiting both JNK1/2 and P38 signaling pathways.

  2016cites this paper
• hypertensive rats and promotes neovascularization in spontaneously Kallikrein gene delivery attenuates cardiac remodeling

  2016cites this paper
• Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy

  2016cites this paper
• Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke

  2015cites this paper
• Roles of Kinins in the Nervous System

  2015cites this paper
• Cardiac fibroblasts as sentinel cells in cardiac tissue: Receptors, signaling pathways and cellular functions.

  2015cites this paper
• Tissue kallikrein-kinin therapy in hypertension and organ damage.

  2014cites this paper
• Relation of Plasma Tissue Kallikrein Levels to Presence and Severity of Coronary Artery Disease in a Chinese Population

  2014cites this paper
• Selective Kinin Receptor Agonists as Cardioprotective Agents in Myocardial Ischemia and Diabetes

  2013cites this paper
• Tissue Kallikrein-Modified Human Endothelial Progenitor Cell Implantation Improves Cardiac Function via Enhanced Activation of Akt and Increased Angiogenesis

  2013cites this paper
• Kallikrein Gene-Modified EPCs Induce Angiogenesis in Rats with Ischemic Hindlimb and Correlate with Integrin αvβ3 Expression

  2013cites this paper
• Anti-apoptotic cardioprotective effects of SHP-1 gene silencing against ischemia-reperfusion injury: use of deoxycholic acid-modified low molecular weight polyethyleneimine as a cardiac siRNA-carrier.

  2013cites this paper
• Human Kallikrein 1,Tissue Kallikrein

  2013cites this paper
• Tissue Kallikrein Reverses Insulin Resistance and Attenuates Nephropathy in Diabetic Rats by Activation of PI3 kinase/Akt and AMPK Signaling Pathways

  2013cites this paper
• Association between the kinin–forming system and cardiovascular pathophysiology

  2012cites this paper
• Tissue Kallikrein Promotes Cardiac Neovascularization by Enhancing Endothelial Progenitor Cell Functional Capacity

  2012cites this paper
• Gene therapy for ventricular tachyarrhythmias

  2012cites this paper
• 8 Kallikrein-kinin system in the heart

  2011cites this paper
• Genetic Variation in ACE-related pathways associated with Sudden Cardiac Arrest Risk

  2010cites this paper
• Human Urinary Kallidinogenase Suppresses Cerebral Inflammation in Experimental Stroke and Downregulates Nuclear Factor-κB

  2010cites this paper
• Attenuation of Doxorubicin-Induced Cardiomyopathy by Endothelin-Converting Enzyme-1 Ablation Through Prevention of Mitochondrial Biogenesis Impairment

  2010cites this paper
• Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing

  2010cites this paper
• Regulation of Kinin Receptor Expression in Heart Failure with a Focus on Vascular Endothelium

  2010cites this paper
• Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice.

  2010cites this paper
• The role of inflammation in the pathophysiology of acute myocardial infarction

  2009cites this paper
• Apoptosis of interstitial cells of Cajal, smooth muscle cells, and enteric neurons induced by intestinal ischemia and reperfusion injury in adult guinea pigs

  2009cites this paper
• Gene Deletion of the Kinin Receptor B1 Attenuates Cardiac Inflammation and Fibrosis During the Development of Experimental Diabetic Cardiomyopathy

  2009cites this paper
• Kallidinogenase normalizes retinal vasopermeability in streptozotocin-induced diabetic rats: potential roles of vascular endothelial growth factor and nitric oxide.

  2009cites this paper
• Cardioprotective effects of benazepril, an angiotensin-converting enzyme inhibitor, in an ischaemia-reperfusion model of myocardial infarction in rats

  2009cites this paper
• Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk.

  2009cites this paper
• Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.

  2008cites this paper
• Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor

  2008cites this paper
• Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model

  2008cites this paper
• function by the Akt-glycogen synthase kinase-3β pathway

  2008cites this paper
• Exogenous kallikrein enhances neurogenesis and angiogenesis in the subventricular zone and the peri-infarction region and improves neurological function after focal cortical infarction in hypertensive rats.

  2008influential citation
• Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion.

  2008cites this paper
• Cardiovascular Activities of of the bradykinin system

  2008cites this paper
• New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration.

  2008cites this paper
• Kinin Infusion Prevents Renal Inflammation, Apoptosis, and Fibrosis via Inhibition of Oxidative Stress and Mitogen-Activated Protein Kinase Activity

  2007cites this paper
• Bradykinin in ischemia-reperfusion injury of the rat lung.

  2007cites this paper
• Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury.

  2007cites this paper
• Cardioprotective actions of peptide hormones in myocardial ischemia

  2007cites this paper
• Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways.

  2007cites this paper
• The Kallikrein-Kinin System and Hypertension

  2007cites this paper
• Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury.

  2006cites this paper
• Kallikrein Protects Against Ischemic Stroke by Inhibiting Apoptosis and Inflammation and Promoting Angiogenesis and Neurogenesis

  2006cites this paper
• Effect of captopril in the presence of kinin B2 receptor antagonist on duration of survival after prolonged coronary artery ligation in hypertensive rats.

  2006cites this paper
• The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction

  2006cites this paper
• Cardioprotective mechanisms of Prunus cerasus (sour cherry) seed extract against ischemia-reperfusion-induced damage in isolated rat hearts.

  2006cites this paper
• Reversal of Renal Fibrosis, Inflammation, and Glomerular Hypertrophy by Kallikrein Gene Delivery

  2006cites this paper
• Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.

  2006cites this paper
• Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system.

  2006cites this paper
• cGMP-dependent Protein Kinase Type I Inhibits TAB1-p38 Mitogen-activated Protein Kinase Apoptosis Signaling in Cardiac Myocytes*

  2006cites this paper
• Postischemic Brain Injury Is Exacerbated in Mice Lacking the Kinin B2 Receptor

  2006cites this paper
• Kinins and cardiovascular diseases.

  2006cites this paper
• Genetic therapies for cardiovascular diseases.

  2005cites this paper
• Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats.

  2005cites this paper
• RNA interference targeting SHP‐1 attenuates myocardial infarction in rats

  2005cites this paper
• A bradykinin antagonist abolishes beneficial effect of captopril on duration of survival after acute coronary artery ligation in hypertensive rats.

  2005cites this paper
• Kallikrein/Kinin Protects against Myocardial Apoptosis after Ischemia/Reperfusion via Akt-Glycogen Synthase Kinase-3 and Akt-Bad·14-3-3 Signaling Pathways*

  2005cites this paper
• Serine proteases and cardiac function.

  2005cites this paper
• Kallikrein Gene Transfer in Hypertension, Cardiovascular and Renal Disease, and Stroke

  2005cites this paper
• Molecular Therapeutic Approaches for Myocardial Protection

  2005cites this paper
• Kallikrein–kinin in stroke, cardiovascular and renal disease

  2005cites this paper
• Cardiovascular Pharmacogenetics

  2004cites this paper
• Activation of the Renin-Angiotensin System After Myocardial Infarction

  2004cites this paper
• Daño miocárdico por reperfusión

  2004cites this paper
• Kallikrein Gene Transfer Protects Against Ischemic Stroke by Promoting Glial Cell Migration and Inhibiting Apoptosis

  2004cites this paper
• Current Perspectives on Gene and Cell-Based Therapies for Myocardial Protection, Rescue and Repair

  2004cites this paper
• Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries

  2004cites this paper
• Tissue Kallikrein Increases Duration of Survival after Prolonged Coronary Artery Ligation in Hypertensive Rats

  2004cites this paper
• Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats

  2004cites this paper
• Endothelium-targeted gene and cell-based therapies for cardiovascular disease.

  2004cites this paper
• Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats.

  2003cites this paper
• Does the Kinin System Mediate in Cardiovascular Abnormalities? An Overview

  2003cites this paper
• Immunohistochemical Distributions of the Tissue Kallikrein‐Kinin System in Ischemic and Non‐Ischemic Mouse Heart

  2003cites this paper
• Effects of ACE Inhibition on Myocardial Apoptosis in an Ischemia–Reperfusion Rat Heart Model

  2003cites this paper
• Evaluation of tissue kallikrein activity on survival time after acute coronary artery ligation in hypertensive rats.

  2003influential citation
• Comparative effects of a vasopeptidase inhibitor vs. an angiotensin convertin enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure

  2003cites this paper
• Renoprotective Effects of Omapatrilat Are Mediated Partially by Bradykinin

  2003cites this paper
• Gene alteration of intestinal intraepithelial lymphocytes in response to massive small bowel resection

  2003cites this paper
• Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats

  2003cites this paper
• Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion.

  2003cites this paper
• Targeting signaling pathways in heart failure by gene transfer

  2003cites this paper
• Apoptosis in myocardial ischaemia and infarction

  2002cites this paper